Century Therapeutics, Inc. (IPSC) - Quarterly Income Statement

Home
IPSC
Financials

1.1 (USD) • At close December 20, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1
Revenue Numbers are in millions	0.791	0.771	0.855	0.268	0.148	0.099	1.72	0.521	2.224	1.396	1.058	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	3.297	3.462	3.226	3.552	1.787	2.409	2.17	3.383	2.774	1.668	21.196	1.885	1.044	0.935	0.948	0	0	0	0
Gross Profit Numbers are in millions	-2.506	-2.691	-2.371	-3.284	-1.639	-2.31	-0.45	-2.862	-0.55	-0.272	-20.138	-1.885	-1.044	-0.935	-0.948	0	0	0	0
Gross Profit Ratio Numbers are in millions	-3.168	-3.49	-2.773	-12.254	-11.074	-23.333	-0.262	-5.493	-0.247	-0.195	-19.034	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	27.228	23.758	20.195	22.296	22.788	22.727	24.899	25.585	25.898	24.494	31.196	21.796	19.545	18.933	15.374	12.442	10.812	8.484	7.943
General & Administrative Expenses Numbers are in millions	8.352	8.306	8.743	8.589	8.986	8.229	8.902	8.242	8.064	8.253	7.298	6.177	6.282	4.088	2.688	2.816	2.319	2.31	2.05
Selling & Marketing Expenses Numbers are in millions	0	0.782	0	-3.552	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	8.352	9.088	8.743	5.037	8.986	8.229	8.902	8.242	8.064	8.253	7.298	6.177	6.282	4.088	2.688	2.816	2.319	2.31	2.05
Other Expenses Numbers are in millions	0	-0.012	0.011	-0.015	0.012	-0.186	-0.194	2.069	1.387	0	10	0	0	0	0.028	0	0	0	0.32
Operating Expenses Numbers are in millions	35.58	32.846	28.938	27.333	31.774	30.956	33.801	33.827	33.962	32.747	38.494	27.973	25.827	23.021	18.062	15.258	13.131	10.794	9.993
Operating Income Numbers are in millions	-34.789	-35.537	-31.309	-30.617	-35.626	-35.077	-32.081	-33.306	-31.738	-31.351	-37.436	-27.973	-25.827	-23.021	-18.062	-15.258	-13.131	-15.516	-9.993
Operating Income Ratio Numbers are in millions	-43.981	-46.092	-36.619	-114.243	-240.716	-354.313	-18.652	-63.927	-14.271	-22.458	-35.384	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	3.555	3.57	3.248	3.495	3.498	2.736	2.025	1.656	1.014	0.381	-0.061	-0.178	-0.182	-0.252	-0.286	-0.273	0.061	0.215	0.32
Income Before Tax Numbers are in millions	-31.234	-31.185	-28.061	-40.267	-32.128	-32.341	-30.056	-31.65	-30.724	-30.97	-37.497	-28.151	-26.009	-23.273	-18.348	-15.531	-13.07	-15.301	-9.673
Income Before Tax Ratio Numbers are in millions	-39.487	-40.447	-32.82	-150.25	-217.081	-326.677	-17.474	-60.749	-13.815	-22.185	-35.441	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	-0.008	0.022	0.001	-0.869	0.592	0.95	1.208	0.032	0.025	0.018	0.016	0.043	0.063	-0.01	0.342	1.04	0.106	0	0.32
Net Income Numbers are in millions	-31.226	-31.207	-28.062	-39.398	-32.72	-33.291	-31.264	-31.682	-30.749	-30.988	-37.513	-28.194	-26.009	-23.273	-18.348	-15.531	-13.07	-15.301	-9.673
Net Income Ratio Numbers are in millions	-39.477	-40.476	-32.821	-147.007	-221.081	-336.273	-18.177	-60.81	-13.826	-22.198	-35.457	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.37	-0.38	-0.45	-0.66	-0.55	-0.56	-0.53	-0.54	-0.53	-0.54	-0.66	-0.52	-0.48	-0.43	-0.33	-0.37	-0.31	-0.37	-0.23
EPS Diluted Numbers are in millions	-0.37	-0.38	-0.45	-0.66	-0.55	-0.56	-0.53	-0.54	-0.53	-0.54	-0.66	-0.52	-0.48	-0.43	-0.33	-0.37	-0.31	-0.37	-0.23
EBITDA Numbers are in millions	-27.937	-27.723	-24.835	-36.715	-30.341	-29.796	-27.482	-27.854	-27.577	-28.972	-37.183	-26.922	-24.643	-22.086	-17.316	-14.685	-12.601	-15.019	-9.414
EBITDA Ratio Numbers are in millions	-35.319	-41.602	-32.846	-100.989	-190.054	-250.01	-17.24	-54.691	-12.434	-20.808	-34.12	0	0	0	0	0	0	0	0

Century Therapeutics, Inc.

NASDAQ:IPSC Add to watchlist

NASDAQ:IPSC